EUVIMEDEUVIMED entdecken
MetaanalyseSystematische ÜbersichtOpen Access · CC BY 4.0

Vitamin D Supplementation for the Outcomes of Patients with Gestational Diabetes Mellitus and Neonates: A Meta-Analysis and Systematic Review

Chunfeng Wu iD, Yang Song, Xueying Wang

International Journal of Clinical Practice · 2023

DOI: 10.1155/2023/1907222 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift International Journal of Clinical Practice, 2023. Verfasst von Chunfeng Wu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics, Shenzhen Longhua Maternity and Child Healthcare Hospital, Shenzhen 51800, China. Hauptthemen laut MEDLINE: Diabetes, Gestational, Pregnancy Complications. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Prevention and timely treatment of gestational diabetes mellitus (GDM) are important to the prognosis of pregnant women and neonates. We aimed to conduct a meta-analysis to evaluate the effects and safety of vitamin D supplementation on GDM patients and neonates, to provide insights into clinical GDM treatment.

Methods

Two authors searched the Medline, PubMed, Cochrane Library, Web of Science, Embase, CNKI, and Wanfang databases for randomized controlled trials (RCTs) on the effects and safety of vitamin D supplementation in GDM patients. The quality of the included RCTs was evaluated according to Cochrane handbook. RevMan 5.3 software was used for statistical analysis.

Results

A total of 20 RCTs involving 1682 GDM patients were finally included, of whom 837 received vitamin D supplementation. Vitamin D supplementation in GDM patients increased the serum 25(OH)D level (SMD = 4.07, 95% CI: (2.73, 5.41)) and HDL level (SMD = 0.41, 95% CI: (0.23, 0.58)) and reduced serum LDL (SMD = −0.49, 95% CI: (−0.68, −0.29)), TG (SMD = −0.59, 95% CI: (−1.01, −0.17)), and TC (SMD = −0.67, 95% CI: (−1.19, −0.14)) levels in GDM patients (all P < 0.05 ). Besides, vitamin D supplementation reduced the risk of premature birth (OR = 0.37, 95% CI: (0.22, 0.62)), hyperbilirubinemia (OR = 0.38, 95% CI: (0.25, 0.58)), and neonatal hospitalization (OR = 0.38, 95% CI: (0.25, 0.58)) of neonates (all P < 0.05 ). No significant publication bias in synthesized results was found (all P > 0.05 ).

Conclusions

Vitamin D supplementation improves the blood lipid level in GDM patients and reduces adverse neonatal outcomes. The dose and duration of vitamin D supplementation for safety need to be further investigated in future high-quality studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes, GestationalPregnancy ComplicationsFemaleHumansInfant, NewbornPregnancyDietary SupplementsVitamin DVitamins

Substanzen

Vitamin DVitamins

Autor:innen und Institutionen

  • Department of Obstetrics, Shenzhen Longhua Maternity and Child Healthcare Hospital, Shenzhen 51800, China.

ORCID-Profile: Chunfeng Wu

Zitieren

APA

Wu, C., Song, Y., & Wang, X. (2023). Vitamin D Supplementation for the Outcomes of Patients with Gestational Diabetes Mellitus and Neonates: A Meta-Analysis and Systematic Review. International Journal of Clinical Practice. https://doi.org/10.1155/2023/1907222

Vancouver

Wu C, Song Y, Wang X. Vitamin D Supplementation for the Outcomes of Patients with Gestational Diabetes Mellitus and Neonates: A Meta-Analysis and Systematic Review. International Journal of Clinical Practice. 2023. doi:10.1155/2023/1907222

BibTeX
@article{Wu2023,
  author = {Wu, Chunfeng and Song, Yang and Wang, Xueying},
  title = {Vitamin D Supplementation for the Outcomes of Patients with Gestational Diabetes Mellitus and Neonates: A Meta-Analysis and Systematic Review},
  journal = {International Journal of Clinical Practice},
  year = {2023},
  doi = {10.1155/2023/1907222}
}
Kostenlos starten →